Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Membranous Nephropathy”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Very early researchNot Yet RecruitingNCT07423572
What this trial is testing

Clinical Study of Anti-CD19/BCMA Universal Chimeric Antigen Receptor T Cells (UCAR-T) in the Treatment of Refractory Idiopathic Membranous Nephropathy (IMN)

Who this might be right for
Refractory Idiopathic Membranous Nephropathy
The First Affiliated Hospital of Zhejiang Chinese Medical University 18
Very early researchNot Yet RecruitingNCT07535138
What this trial is testing

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)IgA Nephropathy (IgAN)
Air Force Military Medical University, China 15
Not applicableStudy completedNCT03880643
What this trial is testing

Rituximab in Refractory Primary Membranous Nephropathy

Who this might be right for
Glomerulonephritis, Membranous
Istanbul University 36
Early research (Phase 1)Looking for participantsNCT07266181
What this trial is testing

Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy

Who this might be right for
Refractory Membranous Nephropathy
The First Affiliated Hospital of Air Force Medicial University 5
Not applicableStudy completedNCT05788211
What this trial is testing

REnal reCOVery After ECMO for Cardiogenic Shock (RECOVECMO)

Who this might be right for
Cardiogenic ShockRenal Replacement TherapyVenoarterial Extracorporeal Membrane Oxygenation
University Hospital, Bordeaux 93
Very early researchNot Yet RecruitingNCT07389499
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)Membranous NephropathyANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN)+2 more
Grit Biotechnology 30
Testing effectiveness (Phase 2)Study completedNCT04893096
What this trial is testing

MOR202 for Refractory MN

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 10
Early research (Phase 1)Not Yet RecruitingNCT07234474
What this trial is testing

A Phase I Study of YK012 in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Excyte Biopharma Ltd 66